HYDERABAD, India, November 30, 2016 /PRNewswire/ --
According to the report "Global Antivenoms Market", published by Market Data Forecast, the global market is projected to reach USD 1,493.2 million by 2021, at a CAGR of 6.12% from 2016 to 2021.
(Logo: http://photos.prnewswire.com/prnh/20160913/406914LOGO )
Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Theses venomous bites result in clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It has been estimated that, approximately 100,000 people die worldwide with snake bites annually. And there is growing demand by public organizations in the most effected regions like Sub-African and Asia-Pacific regions to consider the snake bites as one of the neglected disease by WHO.
Review report description @ http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/
Increasing government initiations to promote the development of high quality antivenom products, presence of highest number of snake bite victims (especially from Asia & Africa regions), and estimated pipeline products launch are driving the growth of global Antivenom Market. In addition, growing of deaths from venomous animal's bites and increasing research to develop advanced antivenom products are further stimulating the growth of global Antivenom Market.
Download free sample report @ http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/request-sample
However, withdrawal of antivenom products from the market by players like Sanofi, insufficient funding to develop the antivenom products to meet demand, high cost of the products, regulatory complexities, and high costs of maintaining livestock for antivenom production are hampering the growth of global Antivenom Market.
The Antivenoms Market is segmented as following:
Based on Application:
Based on Product Type:
Geographical Segmentation:
Some of the key market players operating in the Antivenoms market include Instituto Bioclon, S.A. de C.V. (Mexico), CSL Limited (Australia), Pfizer AG (Switzerland), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), Incepta Vaccine Ltd. (Bangladesh), BTG Plc (U.K.), and Bharat Serum and Vaccines Limited (BSV) (India).
Enquiry Before Buying: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/inquire
The Antivenoms market study offers the following deliverables:
Checkout other related studies in the Therapeutics Segment:
Biopharmaceuticals Market: http://www.marketdataforecast.com/market-reports/global-bio-pharmaceuticals-market-633/
Biosimilars Market: http://www.marketdataforecast.com/market-reports/global-biosimilars-market-1142/
Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/
Antibodies Market: http://www.marketdataforecast.com/market-reports/global-antibodies-market-1177/
Immunotherapy Drugs Market: http://www.marketdataforecast.com/market-reports/global-immunotherapy-drugs-market-1156/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Team Lead (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Share this article